Belam and Cepton Establish Partnership to Enable Safety at High-traffic Railway Level Crossings
23.9.2021 17:00:00 EEST | Business Wire | Press release
Cepton, a Silicon Valley-based innovator of smart lidar solutions has teamed up with Lithuania-based system integrator Belam to improve road user and rail passenger safety by deploying lidar-enabled obstacle detection at railway level crossings. Following the installation of Cepton’s Helius® Smart Lidar System at a busy railway intersection in Europe, the lidar-based solution has monitored over 15,000 train passages with high accuracy to help ensure the safety of pedestrians and other road users. The system has also helped improve the efficiency of the train service and the traffic flow where it is deployed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210923005369/en/
Cepton's lidar sensors are installed at the busy level crossing to monitor a complicated traffic scenario. ©Belam. Photo Credit: Belam
Belam is a full-service system integrator operating in the Baltics and Northern Europe. Utilizing cutting-edge technologies such as lidar, Belam delivers advanced solutions to transform smart cities by improving the safety and efficiency of transportation infrastructure and railway systems. Through its partnership with Cepton, Belam was able to deliver accurate obstacle detection at a busy rail intersection, with an automated system that minimized unnecessary stops. As a result, the traffic flow at the intersection has become more efficient.
Railway level crossings represent one of the most complex traffic scenarios given the variety of road users such as pedestrians, cyclists, cars and trucks, and the potential risk of collisions with trains. The high speed of passing trains can put road users at risk, thereby requiring accurate real-time monitoring of the traffic at the crossings, even in difficult weather conditions, to make sure that the tracks are free of obstacles when the train is about to approach. This has posed major challenges for some of the existing sensor technologies, such as camera and radar. Radars lack the resolution needed to accurately verify, locate and classify the obstacle. Cameras provide 2D imaging without readily-available information about object size, location and speed, and are susceptible to difficult lighting and weather conditions.
To enable 24/7, accurate obstacle detection, Belam tested a few types of sensors, including lidars and microwave radars through their development process. During an extended testing campaign, Belam concluded that, compared to the other sensors tested, Cepton´s Helius Smart Lidar System provided the most reliable results in terms of eliminating false positives and false negatives. As lidars perform well at night and in various environmental conditions, the Vista®-P90 lidars deployed as part of the Helius system outperformed other technologies tested in generating high-resolution 3D imaging of vehicles, people and other objects, twenty-four hours a day. The ground-breaking Helius perception software processed the lidar data to accurately classify objects and track their speeds and locations in real time. Integrated together with other sensors, including CCTV cameras used for recording license plates during traffic violations, and meteorological sensors used to determine weather conditions, Cepton’s lidar solutions enabled a truly intelligent railway crossing by providing the key information needed to deliver comprehensive traffic analytics and trigger the appropriate responses to help save lives.
As a result, Belam’s system has achieved an accuracy of over 99.9% in obstacle detection. This level of accuracy has enabled the level crossing to achieve a higher safety rating, where passing trains are now allowed to pass at almost twice the speed as they used to. Following implementation of the automated system, stop signs, which were previously installed at this intersection to mandate a full stop for all vehicles before crossing, were removed. This has improved the traffic flow at the crossing and increased the operational efficiency of the train service.
Powered by Cepton’s patented MMT ® (Micro Motion Technology), the Vista-P90 lidar offers a wide field of view coverage (90° horizontal x 40° vertical), along with high resolution and long range at an affordable price point. The sensor is rotation-free, frictionless and mirrorless, making it rugged and capable of continuous, outdoor applications, even in harsh weather conditions. With multi-lidar aggregation, edge computing and a low-bandwidth data output, the Helius smart lidar system is easy to integrate, scale up and maintain.
Belam and Cepton’s partnership opens up new applications for lidar-enabled smart cities. The smart rail crossings can extend into a complete V2X solution, where not only trains, but also cars can use the real-time traffic data at the intersections to avoid potential collisions and optimize travel routes. Road authorities could also benefit from traffic analytics based on the number of vehicles and road users and the directions in which they travel across the intersections to generate models and plans for traffic management.
“Cepton´s high-performance lidar solutions played a key role in helping us address the challenging traffic scenario of busy level crossings. Their lidar sensors particularly impressed us with accurate detection of different objects. The beneficial combination of Cepton’s field-tested sensors and advanced perception software provided reliable and accurate real-time analytics,” said Aleksandras Zidokas, Business Director at Belam.
“Our partnership with Cepton has helped us demonstrate the tremendous potential of lidar technology in smart transportation infrastructure. In addition to making railway intersections safer for road users, our lidar-enabled system also brought about marked improvement in the traffic flow. We look forward to deploying Cepton’s solutions at more locations, as a scaled up network of smart lidars could ultimately enable safer and more efficient transit systems, which will ultimately result in reduced carbon emissions and a greener city.”
Dr. Jun Pei, CEO of Cepton added: “Lidar enables a higher level of safety for everyone on the road, not just drivers, and we built our lidar solutions to achieve that goal. Our partnership with Belam enables the next-generation of rail and road safety applications and extends the capabilities of our high performance lidars and perception solutions into the rail market. We look forward to a deeper collaboration with Belam to make safer rail traffic a reality.”
About Cepton Technologies, Inc.
Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. Cepton’s patented MMT®-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in North America, Germany, Japan, India and China, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn.
About Belam
Belam is a company with more than 25 years experience within the Baltic and Nordic market. Today Belam has more than 1000 implemented projects, a developed network of branches both across Lithuania and in other countries. With its experience and a considerable staff, Belam offers its customers the entire scope of services during a project implementation. Professional staff begins its work at the very first stage of the project when the customer is only shaping an idea. The staff helps the customer to transform this idea into a qualitative, secure and effective solution. Owing to financial stability and professionalism of Belam, customers can be sure of the result and the further delivery of qualitative support for the systems built.
Belam is the first integrator company from Baltic countries who was invited to be a member of UNIFE association. Belam are member on UNITEL, and Cybersecurity subgroups.
Belam has on hands experience with different types of sensors and technology’s like Lidar, line scan camera, microwave radar, thermo camera and other.
Belam implemented first in the Baltic states infrastructure for autonomous vehicles V2X in one of high density highway in Lithuania.
For more information, visit: www.belam.eu
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210923005369/en/
Contact information
Cepton: Faithy Li – media@cepton.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 16:07:00 EEST | Press release
Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™, and API Media operations into a new stand-alone public company, which is proposed to be named “API Media”. The Company has reserved the ticker symbol “ADIO” for the proposed spin-out entity and currently intends that API Media will be listed on NASDAQ following completion of the proposed transactions, which remain subject to approval by the Company’s board of directors, definitive agreement, and satisfaction of closing conditions, as well as any regulatory approvals that may be required in connection therewith. The Company has engaged Houlihan Lokey as its financial advisor and Paul Hastings LLP as its lega
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura ® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 15:50:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs). These data were presented (Abstract ID: P0851) today at the 2026 European Academy of Dermatology and Venereology (EADV) Symposium, being held May 7–9, 2026, in Athens, Greece. As previously reported, the TRuE-AD4 study met both of its co-primary endpoints at Week 8, with a statistically significantly higher proportion of patients on Opzelura versus vehicle cream achieving EASI75 (≥75% improvement in Eczema Area and Severity Index score from baseline) and, separately, IGA-TS (Investigator's Global Assessment Treatment Success, defined as an IGA score of 0 [clear] or 1 [almost clear] with at least a two-point improvement from baseline).1 Patients who
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 15:03:00 EEST | Press release
Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L. Saver, MD, UCLA, and Principal Investigator of DISTALS. “What’s important is that both the device and the trial were designed specifically for distal stroke. By using a device built for these small vessels and mea
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 15:00:00 EEST | Press release
Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have faced two critical dining pain points: [Pain Point 1] The Information Gap: Most available resources are tailored for tourists, making it difficult to find the true loc
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 15:00:00 EEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
